Magellan Life Sciences

Magellan Life Sciences is a biotech company in United Kingdom, founded in 2013. It has raised $225K across 1 round, most recently a $225K Seed in November 2017.

Discovering, deciphering, and developing unique plant proteins

Employees
1–10
Founded
2013
Business Model
B2B
Total Funding
$225K
Last Round
$225K SeedNov 2017
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

Magellan Life Sciences is a synthetic biology company that uses its proprietary X-Seed® Precision Respiration™ platform to engineer and commercialize complex plant proteins at industrial scale. Their lead program focuses on Brazzein, a rare natural protein sweetener derived from West African fruit, as a sustainable alternative to sugar and high-fructose corn syrup. The company's platform offers higher yields and simplified downstream purification compared to conventional bioprocessing, targeting the food security and alternative sweetener markets. MLS was part of SOSV's IndieBio 2018 cohort, received Innovate UK grants, and received interest from Roquette Ventures.

Summary

It lists 1–10 employees. It has raised $225K in total across 1 round, most recently a $225K Seed round in Nov 2017. Investors include SOSV.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
SeedSeed RoundNov 2017
$225K

Investors

Similar Companies

Sempra Infrastructure Partners

Sempra Infrastructure develops, builds, operates, and invests in infrastructure serving customers...

San Diego, United States1001–5000Climate Tech
Corporate RoundTotal funding$12.1BSep 2025
Crusoe

AI infrastructure company building renewable-powered data centers and cloud compute optimized for...

Denver, United States201–500Artificial Intelligence, Clean Energy
Series FTotal funding$9.4BSep 2026
CruiseClosed

Self-driving cars.

San Francisco, United States1001–5000Artificial Intelligence, Autonomous Vehicles
Growth EquityTotal funding$6.9BJan 2021
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Stegra

Green steel company using hydrogen and renewable electricity to decarbonize steel production. For...

Stockholm, Sweden201–500Clean Tech, Climate Tech
Venture RoundTotal funding$4.6BJun 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Magellan Life Sciences on Indexed.vc
<a href="https://indexed.vc/companies/magellan-life-sciences"><img src="https://indexed.vc/api/badge/company/magellan-life-sciences" alt="Magellan Life Sciences on Indexed.vc" width="260" height="76" /></a>